Elizabeth A Gamboa

Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.

R. Duvoisin, S. Garg, B. Jeffrey, 2013, Ophthalmology.